Free Trial

Ionis Pharmaceuticals (IONS) SEC Filings & 10K Form

$42.36
+0.85 (+2.05%)
(As of 04:20 PM ET)

Recent Ionis Pharmaceuticals SEC Filings

DateFilerForm TypeView
09/10/2024
4:19 PM
Ionis Pharmaceuticals (Filer)
Form 424B5
09/09/2024
3:33 PM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:23 PM
Ionis Pharmaceuticals (Filer)
Form 424B5
09/04/2024
8:43 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:43 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:51 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:23 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
09/04/2024
8:24 PM
Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144/A
09/04/2024
8:25 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:27 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:29 PM
Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:33 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
8:33 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
09/04/2024
8:40 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:40 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:41 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:19 PM
Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144/A
09/04/2024
8:20 PM
Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144/A
09/04/2024
8:21 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:02 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4/A
09/04/2024
8:06 PM
Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4/A
09/04/2024
8:11 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4/A
09/04/2024
8:13 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
7:51 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4/A
09/04/2024
7:52 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4/A
09/04/2024
7:42 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
7:42 PM
Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/03/2024
6:18 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
4:27 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
2:35 PM
Ionis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/01/2024
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
4:02 PM
BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:02 PM
Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:02 PM
HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:02 PM
Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:03 PM
Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:03 PM
Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:03 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:11 PM
Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
2:13 PM
Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
Form 4/A
07/03/2024
1:48 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
China Stockpiling Gold “Like No Tomorrow” (Ad)

For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .

Click here now to get your free 'De-Dollarization' Guide.
07/03/2024
1:48 PM
Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Hayden Michael R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:52 PM
BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:29 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
9:59 AM
BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
3:33 PM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
6:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
4:25 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:55 PM
Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:50 PM
Ionis Pharmaceuticals (Filer)
Form DEF 14A
04/25/2024
3:52 PM
Ionis Pharmaceuticals (Filer)
Form DEFA14A
04/25/2024
3:53 PM
Ionis Pharmaceuticals (Filer)
Form ARS
04/17/2024
4:16 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
4:19 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
7:59 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
7:50 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2024
5:04 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:52 PM
Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/13/2024
4:52 PM
Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
8:10 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
3:38 PM
Ionis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2024
10:17 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
9:39 AM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
02/16/2024
6:47 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:34 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
5:09 AM
BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
Form SC 13G/A
02/02/2024
6:54 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:54 PM
Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:54 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:31 PM
Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:34 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:21 PM
Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:23 PM
Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
China Stockpiling Gold “Like No Tomorrow” (Ad)

For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .

Click here now to get your free 'De-Dollarization' Guide.
02/02/2024
4:25 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:28 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:30 PM
Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:19 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
9:27 AM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
02/01/2024
9:12 AM
Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144/A
01/31/2024
8:30 PM
Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2024
4:34 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
4:34 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IONS) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners